Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $74,410 | 29 | 91.3% |
| Travel and Lodging | $4,940 | 25 | 6.1% |
| Food and Beverage | $2,077 | 44 | 2.5% |
| Education | $32.40 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $60,793 | 79 | $0 (2021) |
| Novo Nordisk Inc | $20,629 | 19 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $19.41 | 1 | $0 (2018) |
| ZS Pharma. Inc. | $18.98 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $39.45 | 1 | AstraZeneca Pharmaceuticals LP ($39.45) |
| 2020 | $27.41 | 1 | AstraZeneca Pharmaceuticals LP ($27.41) |
| 2019 | $170.29 | 3 | Novo Nordisk Inc ($105.06) |
| 2018 | $7,142 | 21 | AstraZeneca Pharmaceuticals LP ($7,122) |
| 2017 | $74,081 | 74 | AstraZeneca Pharmaceuticals LP ($53,538) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $39.45 | General |
| 01/16/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $31.98 | General |
| 04/16/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $105.06 | General |
| Category: Diabetes | ||||||
| 04/12/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $33.25 | General |
| 12/13/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $35.63 | General |
| 11/08/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.34 | General |
| 09/07/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $44.50 | General |
| 08/23/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/03/2018 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Education | In-kind items and services | $27.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $32.00 | General |
| 06/27/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/22/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $80.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, XARELTO | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | In-kind items and services | $509.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | In-kind items and services | $174.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Travel and Lodging | In-kind items and services | $74.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $46.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Dr. Patrick Boyle, MD
Dr. Patrick Boyle, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Depoe Bay, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184630816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Boyle, MD has received a total of $81,460 in payments from pharmaceutical and medical device companies, with $39.45 received in 2021. These payments were reported across 100 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($74,410).
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Depoe Bay, OR
- Active Since 08/01/2006
- Last Updated 08/11/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1184630816
Products in Payments
- FARXIGA (Drug) $51,205
- Tresiba (Drug) $14,052
- BYDUREON (Drug) $9,236
- Victoza (Drug) $2,670
- Xultophy 100/3.6 (Drug) $2,661
- Xultophy (Drug) $360.00
- Ozempic (Drug) $105.06
- LOKELMA (Drug) $54.41
- BYDUREON DCP (Drug) $33.00
- INVOKANA (Drug) $19.41
- ONGLYZA (Drug) $16.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.